@inproceedings{06171645b79b4a66a80d3b31f437fe00,
title = "Development of an in-house 188W/188Re generator",
abstract = "188Re decays by emitting high-energy beta particles (Emax: 2.1 MeV, Eav: 784 keV), which can be used to kill targeted tumor cells. The short half-life (t1/2 = 16.9 h) of 188Re allows it to be used in targeted radionuclide therapy when linked to peptides or antibodies. 188Re decays with a 155 keV (15%) gamma emission suitable for imaging and dosimetry. Combining these properties make 188Re an ideal theranostic agent in clinical nuclear medicine. Furthermore, 188Re is readily available from a 188W/188Re generator which enables the use of nca 188Re in hospitals and remote locations [1].",
keywords = "188W/188Re generator, radiolabeling, chelator, in house",
author = "{Van de Voorde}, Michiel and Andrew Burgoyne and Bernard Ponsard and Dennis Elema and Thomas Cardinaels and Maarten Ooms",
note = "Score=3",
year = "2020",
month = oct,
day = "30",
doi = "10.1007/s00259-020-04988-4",
language = "English",
volume = "47",
series = "European Journal of Nuclear Medicine and Molecular Imaging ",
publisher = "Springer",
number = "Supplement 1",
pages = "477",
booktitle = "European Journal of Nuclear Medicine and Molecular Imaging",
edition = "suppl. 1",
}